Skip to main content
Clinical Trials/NCT01635634
NCT01635634CompletedNot Applicable

Randomized Controlled Pilot Trial: The Effectiveness of Cupping in Patients With Fibromyalgia

Universität Duisburg-Essen2 sites in 1 country141 target enrollmentStarted: June 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
141
Locations
2
Primary Endpoint
Pain Intensity

Study Overview

Brief Summary

The purpose of this randomized controlled study is to determine the effectiveness of cupping in patients with fibromyalgia compared to sham cupping.

Detailed Description

see above

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • FMS diagnosis according to AWMF Guidelines,
  • necessary documents: medical records
  • Pain intensity > 45mm VAS
  • Participation in cupping twice weekly on appointment

Exclusion Criteria

  • pregnancy
  • other study participation
  • pain due to other rheumatic disease
  • major psychiatric disorder
  • substance abuse
  • severe somatic disorder (cancer)
  • injections, acupuncture, neural therapy within the past 3 months

Arms & Interventions

Sham Cupping

Sham Comparator

Dry Cupping Therapy 5 serial treatments twice weekly 4-8 cups at the upper and lower back

Intervention: Cupping therapy (Other)

Cupping Therapy

Experimental

Dry Cupping 5 serial treatments twice weekly 4-8 cups at the upper and lower back

Intervention: Cupping therapy (Other)

Wait list

No Intervention

Wait list control no specific intervention for 3 weeks study period

Outcomes

Primary Outcomes

Pain Intensity

Time Frame: Day 18

Pain on a 100mm visual analog scale

Secondary Outcomes

  • Fatigue(Day 200)
  • Sleep Quality(Day 200)
  • Quality of life(Day 200)
  • Medication(Day 18)
  • Pain Intensity(Day 200)
  • adverse events(Day 18)
  • Pressure pain sensitivity(Day 18)
  • Disability(Day 200)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jost Langhorst

Prof. Dr. med.

Universität Duisburg-Essen

Study Sites (2)

Loading locations...

Similar Trials